Release of a substance from the human placenta having digoxin-like immunoreactivity

Clin Exp Pharmacol Physiol. 1993 Sep;20(9):603-7. doi: 10.1111/j.1440-1681.1993.tb01747.x.

Abstract

1. The human placental lobule, perfused with a constant flow (5 mL/min) of Krebs' solution after delivery at term, released into the fetal perfusate a digoxin-like substance, as measured by a fluorescence polarization immunoassay. 2. Initially the venous concentration was 360 +/- 66.7 pmol/L digoxin equivalents. This level did not change significantly during fetal vasoconstriction induced by prostaglandin F2 alpha infusion and persisted for the duration of the experiment (1.5-2 h). 3. Infusion into the fetal circulation of Fab fragments of sheep antibodies to digoxin caused vasodilatation, indicated by a fall in perfusion pressure. 4. Thus a digoxin-like immunoreactive substance, previously reported to be present in the placenta, is released into the fetal circulation and may play a role in placental control of fetal vascular tone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Proteins / metabolism*
  • Cardenolides
  • Digoxin*
  • Dinoprost / pharmacology
  • Female
  • Fetal Blood / metabolism
  • Fluorescence Polarization Immunoassay
  • Humans
  • Perfusion
  • Placenta / blood supply
  • Placenta / drug effects
  • Placenta / metabolism*
  • Saponins*
  • Vasoconstriction / drug effects
  • Vasodilation
  • Veins

Substances

  • Blood Proteins
  • Cardenolides
  • Saponins
  • digoxin-like factors
  • Digoxin
  • Dinoprost